Cellectar Biosciences(DE:NV40)
€0.290.00 (0.00%)
DE:NV40
Cellectar Biosciences earnings date
€0.29
At close:0.00 (0.00%)
Cellectar Biosciences (NV40) Q2 2018 Earnings Report
1 Followers
DE:NV40 Q2 2018 EPS Results
- Actual EPS
- -EUR 15.28
- Consensus EPS
- ―
- Beat/Miss
- ―
- One Year Ago EPS
- -EUR 20.79
DE:NV40 Q2 2018 Revenue Results
- Actual Revenue
- EUR 0
- Expected Revenue
- ―
- Beat/Miss
- ―
- YoY Revenue Growth
- ―
Earnings Announcement Details
- Quarter
- Q2 2018
- Date
- 08/10/2018
- Time
- TBA
- Conference Call
- Friday, August 10, 2018
DE:NV40 Upcoming Earnings
Cellectar Biosciences's next earnings date is estimated for March 11, 2027, based on past reporting schedules.
Q2 2018 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q2 2018 Earnings Slide Deck
No slide deck is available for this earnings event.
Q2 2018 Earnings Call Summary
No earnings call summary is available for this earnings event.
DE:NV40 Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Mar 11, 2027 | 2026 (Q4) | -0.44- | 0.59 | ― | ― |
| Nov 10, 2026 | 2026 (Q3) | -0.50-0.42 | -1.27 | 67.38% (+0.86) | |
| Aug 13, 2026 | 2026 (Q2) | -0.47-0.52 | -3.06 | 83.19% (+2.55) | |
| May 14, 2026 | 2026 (Q1) | -1.70-1.20 | -3.8 | 68.33% (+2.59) | |
| Mar 04, 2026 | 2025 (Q4) | -1.110.59 | -1.9 | 130.95% (+2.49) | |
| Nov 13, 2025 | 2025 (Q3) | -2.28-1.27 | -10.85 | 88.25% (+9.57) | |
| Aug 14, 2025 | 2025 (Q2) | -3.36-3.06 | -4.88 | 37.22% (+1.82) | |
| May 13, 2025 | 2025 (Q1) | -4.43-3.80 | -20.07 | 81.08% (+16.27) | |
| Mar 13, 2025 | 2024 (Q4) | -9.56-1.90 | -11.12 | 82.93% (+9.22) | |
| Nov 18, 2024 | 2024 (Q3) | -8.95-10.85 | -23.58 | 53.99% (+12.73) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
